GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. - Wikidata - awgldk - TriplyDB

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.

http://www.wikidata.org/entity/Q37709554

about

Adenocarcinoma of the urinary bladder Infrequent loss of luminal differentiation in ductal breast cancer metastasis GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.A subset of nondescript axillary lymph node inclusions have the immunophenotype of endosalpingiosis A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis.Single Jejunum Metastasis from Breast Cancer Arising Twelve Years after the Initial Treatment.Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification.FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.The ELK3-GATA3 axis orchestrates invasion and metastasis of breast cancer cells in vitro and in vivo.GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.Non-coding RNAs in Mammary Gland Development and Disease.Markers of metastatic carcinoma of breast origin.GATA3 expression in triple-negative breast cancers.A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays.Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness.GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5.Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma-case series and literature review.Low expression of GATA3 promotes cell proliferation and metastasis in gastric cancer.Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer.GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.GATA3 expression in gestational trophoblastic tissues and tumours.MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours.Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.Cutaneous squamous cell carcinoma progression is associated with decreased GATA-3 immunohistochemical staining.GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.

P2860

Q26796705-A2B28EA9-317C-468F-90A4-3313B46339D2 Q28534555-9B2C276E-CD30-4703-8070-D5A09EDB5500 Q34714508-FF82E6A2-8105-4B64-8857-836313AAE5EF Q35087772-767FACA3-7824-4CC3-BBA5-F3F7ACE39357 Q35155656-39323FB3-141F-4513-873C-B8544019B7B0 Q35207272-E58FE006-67CB-453E-B4F5-1BA88F3B517D Q35216700-E7D7FE93-808B-4840-A969-F8811E89808A Q36355868-9B240087-9741-415C-82B8-21A856D32B27 Q37342586-BE05AAF4-D781-438B-A60E-171043F67A4C Q37416678-4759D535-759A-47DC-BDE2-2035B928D4EC Q37619126-B6E53B7A-E342-4B41-BB7B-3A6D141B4B31 Q37662199-9D4187C0-4BED-4694-B740-4054824EC4E3 Q37709857-E5098BEC-12A7-488F-919D-1D169951D29F Q37721452-500E53E4-12D5-46B5-8B1D-7CBF606C959B Q38438463-5348B271-8788-49A5-9DAA-863564CE69B4 Q38667231-50D64CEB-A1BD-4916-8866-4627EF4D8007 Q38696793-D68FC8F6-0D27-40DC-AB2E-DECE06FA803C Q38716068-FA9E379A-F4CF-4678-BAA1-FE5B0816586B Q40090503-1533F11F-014E-49CE-B92E-D9AD46523558 Q41145166-1BC7A723-7E5F-46C3-968D-5ACC25938607 Q41615352-B52D12FC-4994-449E-AC3F-947E986E83AC Q42509280-1E25B5C8-0856-4275-9E7C-E538847F5254 Q46125098-2CA9A5A3-CFE4-4E08-8118-3A2D73C3776F Q47137856-740C5021-0478-458F-A49F-3254BC0CD6C1 Q48005561-A8A2A965-695A-4DAA-9775-FA5E56A3C8A1 Q50013621-9211566A-FAD2-4E74-B06D-81CA03C3B38B Q51168646-EBF69033-CC52-489B-BDCA-5D254148776E Q52960719-DB302CA6-3E61-478B-A48F-2EBE974AF137 Q53179448-29C3152D-1673-47AF-BB38-4E4443237D63 Q53450999-B67434D1-BA25-403F-8F78-45BC39B8469B Q53599776-B443820B-15B3-4C07-B388-BFBAB71D4080 Q53642057-BB0F0F55-0955-4DDA-AC77-FE98205F1FF0 Q54239056-D8ACFD54-5EB6-40D2-85D1-A6E606541B4A

P2860

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.

http://www.wikidata.org/entity/Q37709554

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

GATA3 expression in breast car ...... id, and metastatic carcinomas.

@en

GATA3 expression in breast car ...... id, and metastatic carcinomas.

@nl

type

label

GATA3 expression in breast car ...... id, and metastatic carcinomas.

@en

GATA3 expression in breast car ...... id, and metastatic carcinomas.

@nl

prefLabel

GATA3 expression in breast car ...... id, and metastatic carcinomas.

@en

GATA3 expression in breast car ...... id, and metastatic carcinomas.

@nl

P1433

Q37709554-6D807B4D-B2AC-41A1-84A9-4120E9C5C91C

P1476

Q37709554-AF668B7C-7D37-4B50-B3CD-633AF380A2B8

P2093

Q37709554-01E044EA-B74E-40C3-8F93-BFB174CC79EC

Q37709554-1240CA7D-BC6A-429C-BDB9-D72B0479D867

Q37709554-1ECF8E93-FBB3-4ECB-87D2-03C788528D66

Q37709554-2A600679-467D-4C47-9789-02D60BDEFE0E

Q37709554-34C0F95C-16DD-48E5-8244-02738DCF8111

Q37709554-89F55258-07C0-4F14-A931-CF28CD04F8D4

Q37709554-97DE0323-4274-42F6-84D7-B37B32B668E5

Q37709554-E72BA48F-282C-48F5-A5C0-7F91442DDFD9

Q37709554-F1037D70-B16D-4C43-84F1-EB34AAED9234

P2860

Q37709554-05E3746F-AFD6-4600-8DBE-60B4771A330C

Q37709554-0A2F68E7-6A17-4738-B0A0-DEE3C8CF37A8

Q37709554-0EDEB7B0-CE47-4F49-96DB-EB09581C86DF

Q37709554-139978A3-892C-4E69-8395-493E9FD3643C

Q37709554-16471663-4BAC-48E0-8C26-EC9A535A0660

Q37709554-244E30BE-602E-42CB-B9DB-CFDDBE2DB338

Q37709554-28C3E9D7-220D-48AA-ADF6-5C4AB903815D

Q37709554-2CFCA2B8-3DCE-4A84-A055-6655CE9E65BD

Q37709554-31140A93-6E6A-43F8-8E70-9DE897E9E0C1

Q37709554-392CA426-7CDA-414C-ACD4-EFA187AF9DA8

P304

Q37709554-5C9412BF-5C8C-4413-B6C3-0F2E497B36BE

P31

Q37709554-B0967F7B-DE4C-4F03-9615-8D27F0B39B58

P356

Q37709554-BFD62B6B-54CE-4B26-961B-AB5FA56D6573

P407

Q37709554-00ECE2CE-1BE0-46BC-A3B1-B780D201E2C8

P433

Q37709554-F619A4EB-72B1-4DE9-A017-04C19FDF9D3A

P478

Q37709554-00F78587-E9BB-4217-8535-483AF2B360EE

P577

Q37709554-56BA39D4-8AA4-4661-A499-EA2A86774D59

P698

Q37709554-96DF51F2-122A-4B72-A38D-6015F03C12AA

P932

Q37709554-2FABD7A0-592D-4599-AE6E-5F3F200152E8

P356

J.HUMPATH.2012.11.003

P1433

Human Pathology

P1476

GATA3 expression in breast car ...... id, and metastatic carcinomas.

@en

P2093

Andrea P Subhawong

http://www.w3.org/2001/XMLSchema#string

Ashley Cimino-Mathews

http://www.w3.org/2001/XMLSchema#string

Ben Ho Park

http://www.w3.org/2001/XMLSchema#string

John H Fetting

http://www.w3.org/2001/XMLSchema#string

Marc K Halushka

http://www.w3.org/2001/XMLSchema#string

Pedram Argani

http://www.w3.org/2001/XMLSchema#string

Peter B Illei

http://www.w3.org/2001/XMLSchema#string

Rajni Sharma

http://www.w3.org/2001/XMLSchema#string

Russell Vang

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours

Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway

GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition

GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis

GATA-3 and the regulation of the mammary luminal cell fate

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

P304

1341-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HUMPATH.2012.11.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23375642

http://www.w3.org/2001/XMLSchema#string

P932

3991123

http://www.w3.org/2001/XMLSchema#string